Century Therapeutics Inc (IPSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $299.63M
Last updated: Nov 17, 2026 at 11:06 AM ET
Century Therapeutics Inc (IPSC) Earnings: Report Dates and Results
Century Therapeutics (IPSC) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Century Therapeutics reported EPS of -$0.11, above the -$0.12 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IPSC has an expected report date of Mar 10, 2027.
Earnings History
Of the 23 quarters below that had an estimate, IPSC beat 12, missed 10 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 443.18% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.11 | -$0.12 | -$0.12 - -$0.08 | +8.33% | Beat | N/A | 4 | 1 up, 1 down | Nov 12, 2026 | N/A |
| Jun 30, 2026 | -$0.17 | -$0.11 | -$0.13 - -$0.11 | -54.55% | Miss | N/A | 3 | 2 up, 0 down | Aug 12, 2026 | N/A |
| Mar 31, 2026 | -$0.11 | -$0.17 | -$0.22 - -$0.13 | +35.29% | Beat | -112.4% | 2 | 0 up, 0 down | May 13, 2026 | N/A |
| Dec 31, 2025 | -$0.25 | -$0.30 | -$0.36 - -$0.24 | +15.97% | Beat | N/A | 2 | 2 up, 0 down | Mar 12, 2026 | N/A |
| Sep 30, 2025 | -$0.32 | -$0.38 | -$0.39 - -$0.38 | +15.79% | Beat | N/A | 2 | 1 up, 1 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.38 | -$0.37 | -$0.40 - -$0.35 | -2.70% | Miss | N/A | 2 | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | $0.89 | -$0.31 | -$0.44 - $0.79 | +387.10% | Beat | N/A | 2 | 1 up, 0 down | May 15, 2025 | $109.16M |
| Dec 31, 2024 | -$0.43 | -$0.45 | -$0.47 - -$0.41 | +4.44% | Beat | N/A | 4 | 3 up, 0 down | Mar 19, 2025 | $4.17M |
| Sep 30, 2024 | -$0.37 | -$0.45 | -$0.51 - -$0.41 | +17.78% | Beat | N/A | 5 | 0 up, 0 down | Nov 5, 2024 | $791000 |
| Jun 30, 2024 | -$0.38 | -$0.50 | -$0.61 - -$0.37 | +24.00% | Beat | N/A | 5 | 0 up, 0 down | Aug 8, 2024 | $771000 |
| Mar 31, 2024 | -$0.45 | -$0.45 | -$0.56 - -$0.44 | 0.00% | In line | N/A | 6 | 0 up, 0 down | May 9, 2024 | $855000 |
| Dec 31, 2023 | -$0.65 | -$0.55 | -$0.70 - -$0.40 | -18.18% | Miss | N/A | 7 | 1 up, 0 down | Mar 14, 2024 | $268000 |
| Sep 30, 2023 | -$0.55 | -$0.49 | -$0.58 - -$0.45 | -12.24% | Miss | N/A | 7 | 0 up, 0 down | Nov 9, 2023 | $148000 |
| Jun 30, 2023 | -$0.49 | -$0.54 | -$0.59 - -$0.49 | +9.26% | Beat | N/A | 8 | 0 up, 0 down | Aug 9, 2023 | $99000 |
| Mar 31, 2023 | -$0.53 | -$0.52 | -$0.58 - -$0.44 | -1.92% | Miss | N/A | 9 | 0 up, 0 down | May 11, 2023 | $1.72M |
| Dec 31, 2022 | -$2.27 | -$0.59 | N/A | -284.75% | Miss | N/A | N/A | 0 up, 0 down | Mar 16, 2023 | $521000 |
| Sep 30, 2022 | -$0.53 | -$0.60 | -$0.67 - -$0.52 | +11.67% | Beat | N/A | 9 | 0 up, 0 down | Nov 10, 2022 | $2.22M |
| Jun 30, 2022 | -$0.54 | -$0.50 | -$0.61 - -$0.48 | -8.00% | Miss | N/A | 7 | 0 up, 0 down | Aug 11, 2022 | $1.40M |
| Mar 31, 2022 | -$0.48 | -$0.54 | -$0.57 - -$0.19 | +11.11% | Beat | N/A | 4 | 0 up, 0 down | May 16, 2022 | $1.06M |
| Dec 31, 2021 | -$0.24 | -$0.48 | -$0.50 - -$0.43 | +50.00% | Beat | N/A | 4 | N/A | Mar 17, 2022 | N/A |
| Sep 30, 2021 | -$0.48 | -$0.42 | -$0.43 - -$0.36 | -14.29% | Miss | N/A | 4 | 0 up, 0 down | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$1.93 | -$0.38 | N/A | -407.89% | Miss | N/A | 3 | N/A | Aug 12, 2021 | N/A |
| Mar 31, 2021 | -$2.39 | -$0.44 | N/A | -443.18% | Miss | N/A | N/A | N/A | Jun 21, 2021 | N/A |
| Dec 31, 2020 | -$0.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 | N/A |
| Dec 31, 2019 | -$0.51 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.06, after -$1.63 the year before. It was -$0.51 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.06 | N/A |
| Dec 31, 2024 | -$1.63 | N/A |
| Dec 31, 2023 | -$2.22 | N/A |
| Dec 31, 2022 | -$3.82 | N/A |
| Dec 31, 2021 | -$5.04 | N/A |
| Dec 31, 2020 | -$0.95 | N/A |
| Dec 31, 2019 | -$0.51 | N/A |
Frequently Asked Questions About IPSC
When is Century Therapeutics's next earnings date?
Century Therapeutics's next earnings report is expected for Mar 10, 2027.
Did IPSC beat earnings estimates last quarter?
Yes. Century Therapeutics reported EPS of -$0.11 for the quarter ended Sep 30, 2026, above the -$0.12 estimate, a 8.33% surprise.
What EPS do analysts expect from IPSC next quarter?
The consensus EPS estimate for Century Therapeutics for the quarter ending Dec 31, 2026 is -$0.13 from 8 analysts, with estimates from -$0.14 to -$0.13.
How often does IPSC beat earnings estimates?
Century Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +51.21%.
IPSC pages: Overview, Earnings, Forecast, Financials, Competitors